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Background: Concerns about increased risk of postoperative complications, primarily deep sternal wound infec-
tion (DSWI), prevent liberal use of bilateral internal thoracic artery (BITA) grafting inwomen. Consequently, out-
comes after routine BITA grafting remain largely unexplored in female gender.
Methods:Of 786 consecutivewomenwithmultivessel coronary diseasewho underwent isolated coronary bypass
surgery at the authors' institution from 1999 throughout 2014, 477 (60.7%; mean age: 70 ± 7.7 years) had skel-
etonized BITA grafts; their risk proﬁles, operative data, hospital mortality and postoperative complications were
reviewed retrospectively. Risk factor analysis for hospital death, DSWI and poor late outcomes were performed
by means of multivariable models.
Results: There were 19 (4%) hospital deaths (mean EuroSCORE II: 5.2 ± 6.1%); glomerular ﬁltration
rate b 50 ml/min was an independent risk factor (p = 0.035). Prolonged invasive ventilation (11.3%), multiple
blood transfusion (12.1%) and DSWI (10.7%) were most frequent major postoperative complications. Predictors
of DSWI were body mass index N35 kg/m2 (p = 0.0094), diabetes (p = 0.005), non-elective surgical priority
(p = 0.0087) and multiple blood transfusions (p = 0.016). The mean follow-up was 6.8 ± 4.5 years. The non-
parametric estimates of the 13-year freedom from cardiac and cerebrovascular deaths, major adverse cardiac
and cerebrovascular events, and repeat myocardial revascularization were 76.1 [95% conﬁdence interval (CI):
73.1–79.1], 59.5 (95% CI: 55.9–63.1) and 91.9% (95% CI: 90.1–93.7), respectively. Preoperative congestive heart
failure (p = 0.04) and left main coronary artery disease (p = 0.0095) were predictors of major adverse cardiac
and cerebrovascular events.
Conclusions: BITA grafting could be performed routinely even in women. The increased rates of early postopera-
tive complications do not prevent excellent late outcomes.
© 2016 Elsevier Inc. All rights reserved.
1. Introduction
In coronary artery bypass graft (CABG) surgery as well as in every
cardiac operation, female gender is a predictor of poor early and late
outcomes. In almost all scoring systems speciﬁcally designed to predict
the operative risk after cardiac surgery, female gender is among the risk
factors for hospital, or 30-day mortality [1–4]. In almost all studies
reporting immediate postoperative complications and long-term out-
comes after CABG surgery, the results are worst in women [5,6].
In the last decade, the use of bilateral internal thoracic artery (BITA)
grafting for myocardial revascularization has proven to be useful to
improve long-term survival [7–9], even for high-risk patients such as di-
alysis [10] or insulin-dependent patients [11]. However, the use of BITA
grafting is limited, and sometimes discouraged in women because of
concerns about increased risk of postoperative complications,
primarily deep sternal wound infection (DSWI) [12–14]. Consequently,
outcomes of routine BITA grafting remain largely unexplored in female
gender. This disparity in BITA use by sex should be addressed in the
interest of expanding the beneﬁts of BITA grafting tomore large number
of patients.
The present authors have reviewed retrospectively their 16-year
experience in routine use of BITA grafting in women. The aims of the
study were to report immediate and long-term results and perform a
risk factor analysis for poor outcomes.
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22. Patients and methods
From January 1999 to December 2014, 786 consecutivewomenwith
multivessel coronary artery disease had isolated CABG surgery with at
least one internal thoracic artery (ITA) graft at the authors' institution;
in 477 (60.7%) cases, BITA grafts were used for myocardial revasculari-
zation of the antero-septal and postero-lateral cardiac walls (left-sided
revascularization). The baseline characteristics and risk proﬁles of
these BITA patients are listed in Table 1. The expected operative risk
for each patient was calculated according to the European System for
Cardiac Operative Risk Evaluation II (EuroSCORE II) [1].
The protocols of preoperative evaluation of the suitability of both
ITAs to be used as coronary grafts, of preoperative antibiotic manage-
ment and of perioperative control of hyperglycemia that were adopted
at the authors' institution have been described in previous authors' re-
ports [11,13,15]. The deﬁnitions of preoperative clinical variables and
postoperative complications were the same as have been previously
used by the authors [11,13,15]. All perioperative data were prospective-
ly recorded for every patient in a computerized data registry.
Approval to conduct the studywas acquired from theHospital Ethics
Committee based on retrospective data retrieval; the need for patients
to provide their individual written consent was waived.
2.1. Surgery
The surgical techniques that were used have been previously de-
scribed [11,13,15]. In brief, surgery was carried out via a median
sternotomy with cardiopulmonary bypass and cross-clamping the
aorta. Myocardial protection was achieved with multidose cold blood
cardioplegia delivered in both antegrade and retrograde mode. Off-
pump techniquewas adopted only in the presence of a diffusely athero-
sclerotic ascending aorta (conﬁrmed by epiaortic ultrasonography
scan). Both ITAs were harvested as skeletonized conduits with low-
intensity bipolar coagulation forceps, and used as in-situ grafts when
possible. The right ITAwas preferentially directed to the left anterior de-
scending coronary artery and the left ITA to the postero-lateral cardiac
wall. Additional coronary bypasses were performed with saphenous
vein grafts. Sometimes, the ITA was taken down and used as a free
graft either from the in-situ contralateral ITA (Y-graft) or the proximal
(aortic) end of a saphenous vein graft. The aortic anastomosis of every
venous graft was performed during cross-clamping of the ascending
aorta in on-pump technique, and during aortic side-clamping in off-
pump technique (Table 2).
2.2. Follow-up
An up-to-date clinical follow-up was obtained by a telephonic inter-
view with the patients or their family. The occurrence of at least one
postoperative major adverse cardiac and cerebrovascular event
(MACCE) – deﬁned as any of the following complications from hospital
discharge to follow-up: sudden death, recurrent angina, myocardial in-
farction, congestive heart failure, percutaneous coronary intervention,
reoperation, pulmonary embolism and cerebrovascular accident – was
recorded. For this study, follow-up was closed on December 1st, 2015.
2.3. Statistical methods
Values are number of patients with percentage in brackets, or
mean ± standard deviation with interquartile range in brackets. Risk
factors analysis both for hospital death and DSWI was performed. Clin-
ical variables were compared using the Chi-square, the Fisher's exact or
Table 1
Preoperative patients' characteristics and risk proﬁlesa.
Characteristic n = 477
Age, years 70 ± 7.8 (66–76)
b60 53 (11.1)
60–69 136 (28.5)
70–79 254 (53.2)
N80 34 (7.1)
Hypertension 373 (78.2)
Former smoker 52 (10.9)
Current smoker 10 (2.1)
BMI, kg/m2 26.7 ± 4.3 (23.6–29.3)
N30 91 (19.1)
N35 20 (4.2)
Diabetes on insulin 49 (10.3)
Diabetes on hypoglycemic agent 96 (20.1)
Serum glucose N200 mg/dl 29 (6.1)
Serum hemoglobin, g/l 12.2 ± 1.3 (11.3–13)
b12 207 (43.4)
Poor mobilityb 6 (1.3)
Chronic lung diseaseb 23 (4.8)
GFRc, ml/min 60.2 ± 24.5 (47.7–73)
50–85b 271 (56.8)
b50b 137 (28.7)
Chronic dialysis 10 (2.1)
Extracardiac arteriopathyb 123 (25.8)
Atrial ﬁbrillation 10 (2.1)
Congestive heart failure 44 (9.2)
Unstable angina 245 (51.4)
Recent myocardial infarctionb 117 (24.5)
Coronary artery disease
Left main 159 (33.3)
Two-vessel 56 (11.7)
Three-vessel 344 (72.1)
LVEF, % 56.8 ± 10 (52–60)
30–50b 100 (21)
20–30b 3 (0.6)
b20b 3 (0.6)
Previous PCI 11 (2.3)
Previous CABG surgery (SVGs alone) 2 (0.4)
Critical stateb 39 (8.2)
Use of IABP 13 (2.7)
Surgical priorityb
Elective 150 (31.4)
Urgent 322 (67.5)
Emergency 5 (1)
Expected operative risk (by EuroSCORE IId), % 5.2 ± 6.1 (1.9–6.2)
BMI = body mass index; CABG = coronary artery bypass grafts; EuroSCORE = European
System for Cardiac Operative Risk Evaluation; GFR = glomerular ﬁltration rate;
IABP = intra-aortic balloon pumping; LVEF = left ventricular ejection fraction;
PCI = percutaneous coronary intervention; SD = standard deviation.
a Values are number of patients with percentage in brackets, or mean ± SD with inter-
quartile range in brackets.
b Deﬁnitions were those employed for EuroSCORE II [1].
c The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was
used for approximating the GFR.
d [1].
Table 2
Operative dataa.
Data n = 477
No. of coronary anastomoses 3.5 ± 0.9 (3–4)
With BITA graft 2.6 ± 0.7 (2–3)
With SVGs 0.9 ± 0.8 (0–1)
Use of BITA graft alone 138 (28.9)
Surgical technique
Off-pump 34 (7.1)
Beating heart on-pump 4 (0.8)
On-pump 439 (92)
CPB time, min 97 ± 36.4 (73–115)
Aortic cross-clamping time, min 74.3 ± 25.6 (56–90)
Duration of surgery, min 273.4 ± 65.6 (236–300)
BITA = bilateral internal thoracic artery; CPB = cardiopulmonary bypass;
SD = standard deviation; SVG = saphenous vein graft.
a Values are number of patients with percentage in brackets, or mean ± SD with inter-
quartile range in brackets.
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3the McNemar test for dichotomous variables, and the Student's t or the
Mann–Whitney U-test for continuous variables, as appropriate. Vari-
ables from univariable analysis with a p-value b0.1 were entered into
a multivariable analysis (binary logistic regression model). An odds
ratio (OR)with a 95% conﬁdence interval (CI) was given for each signif-
icant variable. Non-parametric estimates and curves of freedom from
all-cause death (including hospital mortality), cardiac and cerebrovas-
cular deaths (including hospitalmortality),MACCEs, heart failure hospi-
tal readmission, and repeat myocardial revascularization were
generated with the Kaplan–Meier method. Comparisons between sur-
vival curves were made by the log-rank test. The Cox proportional-
hazards model was used to determine the inﬂuence of patients' charac-
teristics and operative ﬁndings on late outcomes. The hazard ratio with
95% CI was calculated for each variable. A p-value b0.05 was considered
to be statistically signiﬁcant. Analyses were performed with IBM SPSS
Statistics (IBM Software Group).
3. Results
3.1. Early (hospital) outcomes
There were 19 (4%) hospital deaths: 14 patients, 2.9%, died within
the postoperative day 30. The causes of death were: stroke (n= 2), re-
spiratory insufﬁciency (n= 2), pneumonia (n= 3), low cardiac output
(n = 2), intestinal necrosis (n = 1), mediastinitis (n = 1) and
multiorgan failure (n=8). According tomultivariable analysis, glomer-
ularﬁltration rate b 50ml/min resulted to be predictor of hospital death
(OR= 2.95, 95% CI: 1.08–8.05; p = 0.035; Table 3). Prolonged invasive
ventilation, multiple blood transfusion and DSWI were most frequent
major postoperative complications (Table 4). According to multivari-
able analysis, body mass index N35 kg/m2 (OR = 4.15, 95% CI:
1.42–12.2; p = 0.0094), diabetes (OR = 2.44, 95% CI: 1.31–4.56; p =
0.005), non-elective surgical priority (OR = 3.31, 95% CI: 1.35–8.11;
p = 0.0087) and multiple blood transfusion (OR = 2.64, 95% CI:
1.2–5.82; p = 0.016; Table 5) were predictors of DSWI.
3.2. Time-related survival
A total of 458 patients were discharged home from the hospital. For
these women, the mean follow-up period was of 6.8 ± 4.5 years
Table 3
Risk factors for hospital death (univariable analysis) (n = 477)a.
Preoperative variable Dead
n = 19
Alive
n = 458
OR 95% CI p-value
Age, years 71.2 ± 9.2 (68–77.5) 70 ± 7.7 (65.2–75) – – 0.5
N75 10 (52.6) 137 (29.9) 2.6 1.03–6.55 0.036
Diabetes on insulin 3 (15.8) 46 (10) 1.68 0.47–5.98 0.43
Serum glucose N200 mg/dl 2 (10.5) 27 (5.9) 1.88 0.41–8.55 0.62
Chronic lung diseaseb 2 (10.5) 21 (4.6) 2.45 0.53–11.3 0.23
GFRc, ml/min 52.8 ± 30.2 (36.4–72.7) 60.5 ± 24.2 (48.5–73) – – 0.18
b50b 11 (57.9) 126 (27.5) 3.62 1.42–9.22 0.0041
Chronic dialysis 2 (10.5) 8 (1.7) 6.62 1.31–33.6 0.056
Extracardiac arteriopathyb 6 (31.6) 117 (25.5) 1.35 0.5–3.62 0.59
Congestive heart failure 3 (15.8) 41 (9) 1.91 0.53–6.82 0.4
Unstable angina 11 (57.9) 234 (51.1) 1.32 0.52–3.33 0.56
Left main coronary disease 8 (42.1) 151 (33) 1.48 0.58–3.75 0.41
LVEF, % 55.8 ± 12.7 (55–60) 56.9 ± 9.9 (52–60) – – 0.65
b30b 1 (5.3) 5 (1.1) 5.03 0.56–45.3 0.22
Critical stateb 4 (21.1) 35 (7.6) 3.22 1.01–10.2 0.06
Urgent surgical priorityb 16 (84.2) 306 (66.8) 2.65 0.76–9.23 0.11
Expected operative risk (by EuroSCORE IId), % 8.8 ± 11.3 (3.3–8.8) 5.1 ± 5.8 (1.9–6.1) – – 0.0044
CI = conﬁdence interval; EuroSCORE = European System for Cardiac Operative Risk Evaluation; GFR = glomerular ﬁltration rate; LVEF = left ventricular ejection fraction; OR = odds
ratio; SD = standard deviation.
a Values are number of patients with percentage in brackets, or mean ± SD with interquartile range in brackets.
b Deﬁnitions were those employed for EuroSCORE II [1].
c The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was used for approximating the GFR.
d [1].
Table 4
Postoperative complications and hospital course of patientsa,b.
Complication n = 477
Neurological dysfunction 27 (5.7)
Delayed awakening 9 (1.9)
Manifest psychiatric disorder 9 (1.9)
Seizures 1 (0.2)
Stroke 8 (1.7)
Critical illness polyneuropathy 3 (0.6)
Prolonged (N48 h) invasive ventilation 54 (11.3)
Pneumonia 41 (8.6)
Permanent hemi-diaphragmatic dysfunction 1 (0.2)
Atrial ﬁbrillation, new-onset 133/467c (28.5)
Myocardial infarction 12 (2.5)
Low cardiac output 19 (4)
Use of inotropes 270 (56.6)
Intra- and postoperative use of IABP 13 (2.7)
Pulmonary embolism 1 (0.2)
Acute kidney injury 29 (6.1)
Renal replacement therapy 7 (1.5)
Bleeding peptic disease 1 (0.2)
Mesenteric ischemia 2 (0.4)
Multiorgan failure 8 (1.7)
48-h Chest tube output/BSA, ml/m2 520 ± 469.2 (278.3–621.6)
Blood transfusion 227 (47.6)
Multiple blood transfusion (N2 RBCs) 58 (12.1)
Mediastinal re-exploration for bleeding or
tamponaded
8 (1.7)
Sternal wound infection 70 (14.7)
Superﬁcial incisional 19 (4)
Deep incisionale 45 (9.4)
Mediastinitise 6 (1.3)
Leg wound complication 6/339f (1.8)
Sepsis 6 (1.3)
Hospital stay, days 16.3 ± 22.1 (8–15)
ICU stay, days 4.3 ± 15.7 (1–3)
BSA = body surface area; DSWI = deep sternal wound infection; IABP = intra-aortic
balloon pumping; ICU = intensive care unit; RBCs = packed red blood cells;
SD = standard deviation.
a Values are number of patients with percentage in brackets, or mean ± SD with
interquartile range in brackets.
b Deﬁnitions of postoperative complications were the same as have been previ-
ously adopted by the authors [11,13,15].
c Patients with preoperative stable sinus rhythm or paroxysmal atrial ﬁbrillation.
d Through resternotomy or subxifoid window.
e DSWI.
f Patients who received concomitant saphenous vein grafts.
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4(median, 6.4 years); overall, 3096.7 patient-years were reviewed. Dur-
ing the follow-up period, there were 80 deaths: 55 (12%) cardiac or ce-
rebrovascular deaths and 25 (5.5%) non-cardiac and non-
cerebrovascular deaths. The causes of deathwere:myocardial infarction
(n= 25), congestive heart failure (n= 22), sudden death (n= 6), pul-
monary embolism (n = 2), malignancy (n = 15), chronic renal failure
(n= 6), sepsis (n = 3) and casualty (n= 1). The non-parametric esti-
mates of the 5-, 10- and 13-year freedom from all-cause death were
88.8 (95% CI: 87.3–90.3), 77.7 (95% CI: 75.4–80) and 68.1% (95% CI:
64.8–71.4), respectively (Fig. 1A). Low glomerular ﬁltration rate, the
New York Heart Association (NYHA) class III–IV, left main coronary dis-
ease and diffusely atherosclerotic ascending aorta were independent
risk factors for all-cause death. The non-parametric estimates of the 5-
, 10- and 13-year freedom from cardiac and cerebrovascular deaths
were 90.6 (95% CI: 89.2–92), 83.1 (95% CI: 81–85.2) and 76.1% (95%
CI: 73.1–79.1), respectively (Fig. 1B). Old age and NYHA class III–IV
were independent risk factors for cardiac and cerebrovascular deaths
(Table 6).
3.3. Functional status
Among the hospital discharged patients, NYHA class improved
from 1.3 ± 0.7, preoperatively, to 1.2 ± 0.5 (p = 0.018); the Canadi-
an Cardiovascular Society class improved from 3.4 ± 0.7 to 1.2 ± 0.6
(p b 0.0001). Overall, 115 (25.1%) patients had 231 MACCEs – cere-
brovascular accident (n = 6), sudden death (n = 8), recurrent angi-
na (n= 41), myocardial infarction (n= 25), congestive heart failure
(n= 124), pulmonary embolism (n= 2), percutaneous coronary in-
tervention (n = 24) and reoperation (n = 1) – and 83 (18.1%) pa-
tients experienced at least one hospital readmission because of
congestive heart failure (Fig. 2). NYHA class III–IV and left main cor-
onary disease were independent risk factors for MACCEs. Chronic
lung disease and left main coronary disease were independent risk
factors for heart failure hospital readmission (Table 6). Among the
25 women who underwent repeat revascularization, signiﬁcant le-
sions of BITA or saphenous vein grafts had been shown with coro-
nary angiography in 28% (7/25) and 57.9% (11/19) of cases,
respectively (p = 0.066); in 48% (12/25) of patients there were
new signiﬁcant lesions of the native coronary tree.
4. Discussion
According to a retrospective United States database analysis per-
formed on 1,526,360 patients who underwent isolated CABG surgery
with at least one ITA between 2002 and 2008, the rate of BITA use was
3.9% and female gender was an independent risk factor for DSWI
(OR = 1.06) [14]. Based on results from a recent analysis performed
by the present authors on 2872 consecutive BITA patients operated on
between 1999 and 2013 in a single institution where BITA grafting is
being routinely performed (N70% of all the cases of isolated CABG sur-
gery), female gender resulted to be an even stronger predictor of
DSWI (OR = 2.96) [13]. Finally, in a series of 11,922 diabetic patients
who underwent primary isolated CABG surgery between 1972 and
2011, the rate of BITA use was 7.9% and female gender was an indepen-
dent risk factor for DSWI (80% increased risk) [12]. These three studies,
and many other reports of Literature support the evidence that:
(i) women are exposed to a higher risk of DSWI after CABG surgery
than men; (ii) the DSWI risk is high for women undergoing routine
BITA grafting; (iii) theDSWI risk after BITA grafting could be almost pro-
hibitive for women with diabetes. In effect, many investigators suggest
to avoid use of BITA grafting for (obese) diabetic women [12,16,17], es-
pecially since the skeletonization technique of ITA harvest could not be
protective for such a patients [12]; besides, the radial artery use has
proven to be a safe option in female gender [18,19]. Thus, there are
Table 5
Risk factors for DSWI (univariable and multivariable analysis) (n = 458)a,b.
Variable Univariable analysis Multivariable analysis
DSWI
n = 51
No sternal complication
n = 407
p-value OR 95% CI p-value
Age, years 70.8 ± 6.6 (66.5–76) 70 ± 7.8 (65.5–75) 0.53 – – –
N70 33 (64.7) 247 (60.7) 0.58 – – –
BMI, kg/m2 28.7 ± 4.8 (25.7–31.6) 26.5 ± 4.2 (23.5–29) 0.00047 – – –
N35 7 (13.7) 12 (2.9) 0.0025 4.15 1.42–12.2 0.0094
Diabetes 25 (49) 111 (27.3) 0.0014 2.44 1.31–4.56 0.005
Serum glucose N200 mg/dl 4 (7.8) 23 (5.7) 0.76 – – –
Chronic lung diseasec 6 (11.8) 16 (3.9) 0.026 2.8 0.95–8.31 0.063
GFRd, ml/min 61.1 ± 26.1 (49.6–75.6) 60 2 ± 4.3 (47.7–72.4) 0.78 – – –
b50c 14 (27.5) 118 (29) 0.82 – – –
Chronic dialysis 1 (2) 8 (2) 0.74 – – –
Extracardiac arteriopathyc 18 (35.3) 98 (24.1) 0.083 – – –
Congestive heart failure 8 (15.7) 34 (8.4) 0.12 – – –
LVEF, % 57.2 ± 8.6 (50.2–60) 56.7 ± 10 (52–60) 0.73 – – –
b50c 13 (25.5) 89 (21.9) 0.56 – – –
Non-elective surgical priorityc 45 (88.2) 269 (66.1) 0.0013 3.31 1.35–8.11 0.0087
Duration of surgery (min) 288.9 ± 65.5 (245–318) 270.9 ± 66.2 (234–295) 0.067 – – –
N360 6 (11.8) 23 (5.7) 0.19 – – –
Postoperative
Low cardiac outpute 2 (3.9) 17 (4.2) 0.64 – – –
Multiple blood transfusion (N2RBCs) 14 (27.5) 41 (10.1) 0.00032 2.64 1.2–5.82 0.016
Mediastinal re-exploration for bleeding or tamponadef 3 (5.9) 5 (1.2) 0.049 2.97 0.5–17.6 0.23
BMI = body mass index; DSWI = deep sternal wound infection; EuroSCORE = European System for Cardiac Operative Risk Evaluation; GFR = glomerular ﬁltration rate; LVEF = left
ventricular ejection fraction; RBCs = packed red blood cells; SD = standard deviation.
a Values are number of patients with percentage in brackets, or mean ± SD with interquartile range in brackets.
b Patients with superﬁcial incisional sternal wound infection were excluded from this analysis.
c Deﬁnitions were those employed for the EuroSCORE II [1].
d The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was used for approximating the GFR.
e Deﬁnition was the same as has been previously adopted by the authors [11, 13, 15].
f Through resternotomy or subxifoid window.
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5disparities in ITA use by sex and both single and bilateral ITA grafts are
used less frequently in women than in men [20,21]. Consequently, out-
comes of routine BITA grafting remain largely unexplored in female
gender and any conclusion concerning the use of BITA grafts in
women derives inevitably from clinical experienceswhere BITA grafting
is performed in low-risk female patients [22].
Since 1986 BITA grafting has been performed routinely at the au-
thors' institution but only since 1999 have all perioperative data for
every patient been prospectively recorded in a computerized data regis-
try. The rate of BITA use is increased from ~60% in 1999 to over 90% in
2014. All patients with multivessel coronary artery disease needing
left-sided myocardial revascularization were potential candidates for
BITA grafting. The sole exceptions have been: (i) the rare cases where
one or both ITAs were unsuitable as coronary grafts; (ii) when there
was an unexpected operative ﬁnding of severe cardiac dysfunction;
(iii) when a rapid ischemicworsening of hemodynamics needed imme-
diate institution of cardiopulmonary bypass [11,13,15]. Between 1999
and 2014, BITA grafts have been used in 74.3% of men and 60.7% of
women who underwent isolated multiple CABG surgery with at least
one ITA graft. Compared to other experiences on the subject [22], BITA
grafts have been used more frequently, and the percent of BITA use in
women was twice higher.
In the present study, outcomes of a large series of women who have
undergone routine BITA grafting were speciﬁcally reviewed in order to
Fig. 1.Non-parametric curves of freedom from (A) all-cause death and (B) cardiac and cerebrovascular deaths (including hospital mortality) during the follow-up period. CI= conﬁdence
interval; HR = hazard ratio.
44 G. Gatti et al. / Cardiovascular Revascularization Medicine 18 (2017) 40–46
6establish the risk factors for hospital mortality, DSWI and poor late re-
sults of BITA surgery in female gender. The hospital mortality was only
a little lower than expected according to EuroSCORE II and glomerular
ﬁltration rate b 50 ml/min resulted to be predictor of death. The risk
proﬁles of patients were equivalent to those of other series of women
who underwent isolated CABG surgery [5,6] but higher than those of
other series of women who underwent isolated BITA grafting [22].
This was due to the high mean age (over 60% of the patients had
70 years or more; about 7% were octogenarians) and the high rates of
severe renal impairment and extracardiac arteriopathy. Besides, diabe-
tes on insulin, morbid obesity, chronic lung disease, renal replacement
therapy, previous CABG surgery, critical state and emergency priority
were not exclusion criteria from BITA grafting for the women of this
study. There were frequent postoperative complications. Prolonged in-
vasive ventilationwas favored by a history of smoking, chronic lung dis-
ease, prolonged aortic cross-clamping and cardiopulmonary bypass
times, airway infections, acute kidney injury, multiple blood transfusion
and mediastinal re-exploration. Fortunately, phrenic nerve paralysis
was a rare and self-resolving complication and there was only one
case of permanent hemi-diaphragmatic dysfunction. Blood use was
increased due to preoperative anemia (chronic renal failure), periop-
erative bleeding and prolonged cardiopulmonary bypass time. Ster-
nal wound infection was an expected and frequent postoperative
complication. It was more frequent than reported in other series of
CABG patients that include men and women (at the present authors'
institution, the rate of DSWI after isolated BITA grafting in men was
3.7%) [7,14,16,17]. The higher rate of DSWI was in all probability
due to the use of BITA grafts on a routine basis without any preoper-
ative selection of candidates for left-sided BITA grafting [11,13,15].
Body mass index N35 kg/m2, diabetes, non-elective surgical priority
and multiple blood transfusion were predictors of DSWI. Chronic
lung disease and mediastinal re-exploration resulted to be risk fac-
tors according to univariable but not multivariable analysis. Unlike
what has previously been reported by some authors [23], off-pump
surgery was not a protective factor for DSWI [14,17]. In the present
study, however, off-pump technique has been used exclusively to
avoid clamping a calciﬁed ascending aorta [11,13,15]. Acute kidney
injury was a relatively rare complication despite the frequent preop-
erative renal impairment, prolonged cardiopulmonary bypass time
and multiple blood transfusion. The right ITA was preferentially
used as in-situ graft (up to 80% of all cases); when the right ITA
was used as a free graft, it was preferably anastomosed to the in-
situ left ITA (Y-graft). Probably due to the institutional policy of
reduced aortic manipulation and the routine use of epiaortic ultraso-
nography scanning, the rate of irreversible neurological complica-
tions was b2%.
During the follow-up period, there was a signiﬁcant symptomatic
improvement for the patients. Like other similar experiences on the
topic [22], the estimates of the long-term freedom from all-cause
death, cardiac and cerebrovascular deaths, MACCEs, heart failure hospi-
tal readmission, and repeat myocardial revascularization for these
womenwho had undergone BITA graftingwere very good. The late out-
comes compared favorably with those of previous studies on CABG sur-
gery with single ITA in women [5,6] but were equivalent to those of
previous investigations on CABG surgery with left ITA and radial artery
inwomen [18,19]. Actually, not all of these studies included hospital (or
30-day) mortality into the non-parametric estimates of survival. Ac-
cording to multivariable analysis, old age, chronic lung disease, low glo-
merular ﬁltration rate and diffusely atherosclerotic ascending aorta
were predictors of cardiac and cerebrovascular deaths, heart failure hos-
pital readmission, all-cause death and MACCEs, respectively; NYHA
class III–IV was shared predictor of all-cause death, cardiac and cerebro-
vascular deaths and MACCEs; left main coronary disease was shared
predictor of all-cause death,MACCEs and heart failure hospital readmis-
sion. Although the use of BITA graft alone was combined with a lower
risk both for MACCEs and repeat myocardial revascularization, the sig-
niﬁcancewas not achieved. In effect, (i) the BITA grafting alone strategy
[24] was adopted not for every patient with two-vessel coronary artery
disease; (ii) one or more new signiﬁcant lesions had been shown with
coronary angiography not only in the native coronary tree but also in
~30% of the BITA grafts out of the patients who underwent repeat myo-
cardial revascularization.
The primary limitation of the present study was the retrospective
nature of the analysis and that the patients were evaluated at different
times after surgery. No comparison was made as the results between
skeletonized and pedicled BITA grafts, off- and on-pump BITA grafting
or bilateral and single ITA use. Coronary angiography was performed
only in few strongly symptomatic patients; therewas nodirect informa-
tion about patency of BITA grafts in all the remaining patients. Conse-
quently, the results obtained can in no way be considered conclusive
and should be veriﬁed in a larger patient population by means of pro-
spective controlled trials that include angiographic evaluations.
In conclusion, on the basis of the ﬁndings of the present study, BITA
grafting could be performed routinely even in women. The increased
rates of early postoperative complications, primarily sternal wound in-
fections, do not prevent excellent late outcomes.
Table 6
Cox proportional-hazards regression for all-cause death, cardiac and cerebrovascular deaths, MACCEs, HF hospital readmission and repeat MR during the follow-up period (n = 458).
Preoperative variable All-cause death Cardiac and
Cerebrovascular deaths
MACCEs HF hospital readmission Repeat MR
HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value
Age, years 1.03 0.99–1.06 0.13 1.04 1–1.09 0.032 1.01 0.99–1.04 0.36 1 0.97–1.03 0.89 0.96 0.92–1 0.058
Diabetes 1.6 1–2.55 0.051 1.41 0.8–2.49 0.24 1.29 0.86–1.94 0.22 1.1 0.68–1.78 0.69 – – –
Chronic lung diseasea 0.92 0.33–2.56 0.88 – – – 1.51 0.7–3.29 0.3 2.54 1.15–5.62 0.022 – – –
GFRb, ml/min 0.98 0.97–1 0.013 – – – 1 0.99–1.01 0.47 0.99 0.98–1.01 0.37 – – –
Extracardiac arteriopathya 1.49 0.92–2.41 0.1 1.5 0.84–2.7 0.17 1.05 0.68–1.61 0.83 – – – – – –
Congestive heart failure 2.7 1.56–4.67 0.0004 3.01 1.56–5.79 0.001 1.81 1.03–3.19 0.04 0.84 0.37–1.92 0.69 – – –
Left main coronary artery disease 1.61 1.02–2.54 0.042 1.42 0.82–2.48 0.22 1.66 1.13–2.43 0.0095 1.95 1.26–3.03 0.0029 1.88 0.85–4.14 0.12
LVEF, % – – – – – – 1.02 1–1.04 0.05 1.01 0.98–1.03 0.6 – – –
BITA graft alone – – – – – – 0.73 0.48–1.12 0.15 1 0.63–1.59 0.99 0.59 0.25–1.57 0.32
Diffusely atherosclerotic ascending
aorta (by EAS)
2.27 1.22–4.21 0.0097 1.64 0.73–3.7 0.23 1.53 0.8–2.94 0.2 – – – – – –
BITA = bilateral internal thoracic artery; CI = conﬁdence interval; EAS = epiaortic ultrasonography scan; GFR = glomerular ﬁltration rate; HF = heart failure; HR = hazard ratio;
LVEF = left ventricular ejection fraction; MACCE = major adverse cardiac and cerebrovascular event; MR = myocardial revascularization.
a Deﬁnitions were those employed for the EuroSCORE II [1].
b The creatinine clearance rate, calculated according to the Cockcroft–Gault formula, was used for approximating the GFR.
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Fig. 2. Non-parametric curves of freedom from (A) MACCEs, (B) HF hospital readmission
and (C) repeat myocardial revascularization during the follow-up period. The non-
parametric estimates of the 5-, 10- and 13-year freedom from MACCEs were 84.1 (95%
CI: 82.3–85.9), 70.2 (95% CI: 67.5–72.9) and 59.5% (95% CI: 55.9–63.1), respectively. The
non-parametric estimates of the 5-, 10- and 13-year freedom from HF hospital
readmission were 88.1 (95% CI: 86.5–89.7), 78 (95% CI: 75.6–80.4) and 70.1% (95% CI:
66.7–73.5), respectively. The non-parametric estimates of the 5-, 10- and 13-year
freedom from repeat myocardial revascularization were 96.1 (95% CI: 95.2–97), 94 (95%
CI: 92.7–95.3) and 91.9% (95% CI: 90.1–93.7), respectively. CI = conﬁdence interval;
HF = heart failure; MACCE =major adverse cardiac and cerebrovascular event.
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